drugset / Trial / NCT01627639

Effectiveness of Acetazolamide for Reversal of Metabolic Alkalosis in Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients

NCT01627639

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether acetazolamide are effective to reduce the length of mechanical ventilation in decompensated Chronic Obstructive Pulmonary Disease (COPD) patients developing pure or mixed metabolic alkalosis.

Timeline

Start
2011-10
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetazolamide Small molecule 1 g Intravenous
Comparator Acetazolamide Small molecule 2 g Intravenous